Drug dependence during pregnancy. Effect of an on-site support group.
To examine the clinical and economic efficacy of an on-site support group for drug-abusing pregnant women enrolled in an urban, hospital-based obstetric clinic. Maternal and neonatal outcomes and medical cost data were compared for drug-abusing pregnant women who attended (n = 54) and did not attend (n = 67) a weekly substance abuse support group in the obstetric clinic. Clinical and economic outcomes were more favorable for support group attenders than nonattenders. Specifically, infants of support group attenders had higher birth weights and better 1-minute Apgar scores. In addition, average short-term medical care costs were nearly $1,000 (maternal) and > $1,500 (infant/neonatal) lower for support group attenders as compared to nonattenders. Support group attendance was associated with short-term clinical and economic benefits that are likely to translate into longer-term cost savings. The findings suggest that a weekly substance abuse support group can provide low-cost, well-accepted and effective therapeutic services for this high-risk population of women.